```json
{
"content": [
{
"type": "paragraph",
"content": "The Polypectomy Forcep ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream healthcare providers. Value is generated through precision manufacturing, regulatory compliance, and clinical efficacy, with stakeholders collaborating to ensure safe, effective polypectomy procedures globally."
},
{
"type": "list",
"items": [
{ "text": "Raw material/component suppliers โ Supply stainless steel, polymers, and coatings for forcep production.", "level": 1 },
{ "text": "OEMs/Manufacturers โ Design and produce polypectomy forceps to medical-grade specifications.", "level": 1 },
{ "text": "Technology providers โ Develop advanced sterilization and ergonomic design solutions.", "level": 1 },
{ "text": "Distributors/Channel partners โ Facilitate distribution to hospitals and endoscopy centers.", "level": 1 },
{ "text": "End users โ Hospitals, clinics, and ambulatory surgical centers utilizing forceps for polypectomy procedures.", "level": 1 },
{ "text": "Regulators/Standards bodies โ Oversee compliance with FDA, ISO, and CE marking requirements.", "level": 1 },
{ "text": "Service providers/After-sales โ Offer maintenance, repair, and user training for device longevity.", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Control points include regulatory bodies dictating approval pathways and OEMs influencing product adoption. Dependency risks arise from raw material availability and compliance with evolving standards. End users face high switching costs due to specialized training and device interoperability with endoscopy systems. Partnerships between manufacturers and distributors are critical to navigating fragmented healthcare procurement channels."
}
]
}
```